Nutriband Inc. Profile Avatar - Palmy Investing

Nutriband Inc.

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transd…

Biotechnology
US, Orlando [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Nutriband Inc. has no acquisition track records yet.

M&A Deals · History

Nutriband Inc. has no acquisition track records yet.

End of NTRB's Analysis
CIK: 1676047 CUSIP: 67092M208 ISIN: US67092M2089 LEI: - UEI: -
Secondary Listings
NTRB has no secondary listings inside our databases.